Home > Insider Trading > Filing (0001225208-17-018664)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1494319	Univar Inc.	UNVR	Wholesale-Chemicals & Allied Products (5160)	261251958

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644764	John Mark Byrne	15165 Via Del Sur Monte Sereno CA 95030		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2017-12-12	49,500	$18.54	63,994	No	4	M	Direct
Common Stock	Disposition	2017-12-12	49,500	$29.16	14,494	No	4	S	Direct
Common Stock	Acquisiton	2017-12-13	40,534	$18.54	55,028	No	4	M	Direct
Common Stock	Disposition	2017-12-13	40,534	$29.10	14,494	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Options (right to buy)	Disposition	2017-12-12	49,500	$0.00	49,500	$18.54
Common Stock	Stock Options (right to buy)	Disposition	2017-12-13	40,534	$0.00	40,534	$18.54

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
202,453	2014-02-01	2024-02-01	No	4	M	Direct
161,919	2014-02-01	2024-02-01	No	4	M	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.061 to $29.365, inclusive. The Reporting Person understakes to provide Univar Inc., any of its security holders, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each seperate price within the range set forth in footnotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.97 to $29.215, inclusive.
These options were granted on February 1, 2014 and became vested and exercisable in 12 installments beginning on the grant date and ending on Decemember 28, 2014.